Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors Portfolio News / By Karina Tin July 1, 2024 Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors Read More »
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy Portfolio News / By Karina Tin June 18, 2024 Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy Read More »
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) Portfolio News / By Karina Tin June 16, 2024 Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) Read More »
InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases Portfolio News / By Karina Tin June 13, 2024 InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases Read More »
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer Portfolio News / By Karina Tin June 11, 2024 Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer Read More »
Incyte Completes Acquisition of Escient Pharmaceuticals Portfolio News / By Karina Tin May 30, 2024 Incyte Completes Acquisition of Escient Pharmaceuticals Read More »
A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Portfolio News / By Karina Tin May 29, 2024 A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Read More »
Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer Portfolio News / By Karina Tin May 28, 2024 Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer Read More »
A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T Portfolio News / By Karina Tin May 16, 2024 A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T Read More »
(Carmot) Roche Reports Positive Phase Ib Results For Its Dual GLP-1/GIP Receptor Agonist CT-388 in People with Obesity Portfolio News / By Karina Tin May 16, 2024 (Carmot) Roche Reports Positive Phase Ib Results For Its Dual GLP-1/GIP Receptor Agonist CT-388 in People with Obesity Read More »
